نتایج جستجو برای: 1775 mjm

تعداد نتایج: 1555  

2017
Cody W. Lewis Zhigang Jin Dawn Macdonald Wenya Wei Xu Jing Qian Won Shik Choi Ruicen He Xuejun Sun Gordon Chan

Wee1 kinase is a crucial negative regulator of Cdk1/cyclin B1 activity and is required for normal entry into and exit from mitosis. Wee1 activity can be chemically inhibited by the small molecule MK-1775, which is currently being tested in phase I/II clinical trials in combination with other anti-cancer drugs. MK-1775 promotes cancer cells to bypass the cell-cycle checkpoints and prematurely en...

Journal: :McGill Journal of Medicine 2020

2014
Wenxiu Qi Chengzhi Xie Chunhuai Li J Timothy Caldwell Holly Edwards Jeffrey W Taub Yue Wang Hai Lin Yubin Ge

BACKGROUND Acute myeloid leukemia (AML) remains a difficult disease to treat and requires new therapies to improve treatment outcome. Wee1 inhibitors have been used to prevent activation of the G2 cell cycle checkpoint, thus enhancing the antitumor activity of DNA damaging agents. In this study, we investigated MK-1775 in AML cell lines and diagnostic blast samples to identify sensitive subtype...

Journal: :Journal of cancer survivorship : research and practice 2010
Karen L Syrjala Jean C Yi Samantha B Artherholt Allison C Stover Janet R Abrams

INTRODUCTION Beyond documentation of high prevalence rates, research has not examined the qualities and characteristics of musculoskeletal symptoms in cancer survivors, possibly because measures have not been validated specifically for the assessment of these symptoms in survivors. We report here on a new measure of muscle and joint symptoms for survivors of hematologic malignancies and hematop...

Journal: :McGill Journal of Medicine 2020

2011
N. V. Rajeshkumar Elizabeth De Oliveira Niki Ottenhof James Watters David Brooks Tim Demuth Stuart D. Shumway Shinji Mizuarai Hiroshi Hirai Anirban Maitra Manuel Hidalgo

Purpose: Investigate the efficacy and pharmacodynamic effects of MK-1775, a potent Wee1 inhibitor, in both monotherapy and in combination with gemcitabine (GEM) using a panel of p53-deficient and p53 wild-type human pancreatic cancer xenografts. Experimental Design: Nine individual patient-derived pancreatic cancer xenografts (6 with p53-deficient and 3 with p53 wild-type status) from the PancX...

2013
Amy D. Guertin Jing Li Yaping Liu Melissa S. Hurd Alwin G. Schuller Brian Long Heather A. Hirsch Igor Feldman Yair Benita Carlo Toniatti Leigh Zawel Stephen E. Fawell D. Gary Gilliland Stuart D. Shumway

Inhibitionof theDNAdamage checkpoint kinaseWEE1potentiates genotoxic chemotherapies by abrogating cell-cycle arrest and proper DNA repair. However, WEE1 is also essential for unperturbed cell division in the absence of extrinsic insult. Here, we investigate the anticancer potential of a WEE1 inhibitor, independent of chemotherapy, and explore a possible cellular context underlying sensitivity t...

Journal: :McGill Journal of Medicine 2020

2009
Abicumaran Uthamacumaran Charles Vincent Rajadurai Morag Park

In our true scholarly spirit, the MJM remains committed to supporting budding scientist at all stages of their careers. This year we are pleased to provide you with a unique collection of abstracts outlining the high caliber projects that were undertaken by the most recent winners of the 27th annual Montreal Regional Science and Technology Fair (MRSTF) that was held at Marianopolis College from...

2014
Paul Dent

CommenTAry CommenTAry I t has been known for many years that manipulation of cell cycle checkpoint function represents one approach by which the toxicity of chemotherapy and of ionizing radiation can be increased in tumor cells. The mitotic cell cycle checkpoint is regulated by the kinase CDK1, which in turn is regulated by both ATM/ATR-CHK1/2-CDC25C signaling and by the tyrosine kinase WEE1. H...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید